General Information of the Compound
| Compound ID |
CP0465035
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]-4-[2-[2-[2-[2-[[4-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butylcarbamoyl]phenyl]methoxy]ethoxy]ethoxy]ethoxy]ethoxymethyl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C54H76N6O9
|
||||||||||||||||||
| Molecular Weight |
953.235
|
||||||||||||||||||
| Canonical SMILES |
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(cc3)C(=O)NCCCCN3CCN(CC3)c3ccccc3OC)cc2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C54H76N6O9/c1-63-51-13-5-3-11-49(51)59-31-27-57(28-32-59)25-9-7-23-55-53(61)47-19-15-45(16-20-47)43-68-41-39-66-37-35-65-36-38-67-40-42-69-44-46-17-21-48(22-18-46)54(62)56-24-8-10-26-58-29-33-60(34-30-58)50-12-4-6-14-52(50)64-2/h3-6,11-22H,7-10,23-44H2,1-2H3,(H,55,61)(H,56,62)
Show/Hide
|
||||||||||||||||||
| InChIKey |
BYUVKVSQQDHYKB-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Protein ID: PT01161, D(4) dopamine receptor